Artemisinin combination therapies.
Duffy
Patrick E
PE
Malaria Program, Seattle Biomedical Research Institute, Seattle, WA 98109, USA. patrick.duffy@sbri.org
Mutabingwa
Theonest K
TK
D000328:Adult; D000349:Africa; D000962:Antimalarials / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D037621:Artemisinins / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D000077332:Artesunate; D001208:Asia; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy*; D015767:Mefloquine / Q000008:administration & dosage / Q000627:therapeutic use; D011804:Quinolines / Q000008:administration & dosage / Q000627:therapeutic use; D012717:Sesquiterpenes / Q000008:administration & dosage / Q000627:therapeutic use; D010879:Piperazines
D000962:Antimalarials; D037621:Artemisinins; D000077332:Artesunate; D015767:Mefloquine; D011804:Quinolines; D012717:Sesquiterpenes; C039060:artenimol; C034759:piperaquine; D010879:Piperazines